J&J sees AI halving the time to generate drug development leads
World 14:18 28/04/2026NEW YORK -- Johnson & Johnson (JNJ.N) is using artificial intelligence to slash by half the time it takes to generate new leads for developing drugs, the company's chief information officer said on Monday.